Abstract:Conotoxins are small and highly potent neurotoxic peptides derived from the venom of marine cone snails which have captured the interest of the scientific community due to their pharmacological potential. These toxins display significant sequence and structure diversity, which results in a wide range of specificities for several different ion channels and receptors. Despite the recognized importance of these compounds, our ability to determine their binding targets and toxicities remains a significant challenge. Predicting the target receptors of conotoxins, based solely on their amino acid sequence, remains a challenge due to the intricate relationships between structure, function, target specificity, and the significant conformational heterogeneity observed in conotoxins with the same primary sequence. We have previously demonstrated that the inclusion of post-translational modifications, collisional cross sections values, and other structural features, when added to the standard primary sequence features, improves the prediction accuracy of conotoxins against non-toxic and other toxic peptides across varied datasets and several different commonly used machine learning classifiers. Here, we present the effects of these features on conotoxin class and molecular target predictions, in particular, predicting conotoxins that bind to nicotinic acetylcholine receptors (nAChRs). We also demonstrate the use of the Synthetic Minority Oversampling Technique (SMOTE)-Tomek in balancing the datasets while simultaneously making the different classes more distinct by reducing the number of ambiguous samples which nearly overlap between the classes. In predicting the alpha, mu, and omega conotoxin classes, the SMOTE-Tomek PCA PLR model, using the combination of the SS and P feature sets establishes the best performance with an overall accuracy (OA) of 95.95%, with an average accuracy (AA) of 93.04%, and an f1 score of 0.959. Using this model, we obtained sensitivities of 98.98%, 89.66%, and 90.48% when predicting alpha, mu, and omega conotoxin classes, respectively. Similarly, in predicting conotoxins that bind to nAChRs, the SMOTE-Tomek PCA SVM model, which used the collisional cross sections (CCSs) and the P feature sets, demonstrated the highest performance with 91.3% OA, 91.32% AA, and an f1 score of 0.9131. The sensitivity when predicting conotoxins that bind to nAChRs is 91.46% with a 91.18% sensitivity when predicting conotoxins that do not bind to nAChRs.

Computational Design of α-Conotoxins to Target Specific Nicotinic Acetylcholine Receptor Subtypes

Computational determination of the binding mode of α-conotoxin to nicotinic acetylcholine receptor

Rational Design of -Conotoxin RegIIA Analogues Selectively Inhibiting the Human 32 Nicotinic Acetylcholine Receptor through Computational Scanning

Alpha-Conotoxins Active At Alpha 3-Containing Nicotinic Acetylcholine Receptors And Their Molecular Determinants For Selective Inhibition

Rational Design of α-Conotoxin RegIIA Analogues Specifically Inhibiting the Human α3β2 Nicotinic Acetylcholine Receptor through Computational Scanning.

Blockade of Neuronal Α7-Nachr by Α-Conotoxin ImI Explained by Computational Scanning and Energy Calculations

Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor

Machine Learning Framework for Conotoxin Class and Molecular Target Prediction

Conotoxin Αd-Gexxa Utilizes a Novel Strategy to Antagonize Nicotinic Acetylcholine Receptors.

Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.

Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.

High-Affinity α-Conotoxin PnIA Analogs Designed on the Basis of the Protein Surface Topography Method

Dimerization of alpha-Conotoxins as a Strategy to Enhance the Inhibition of the Human alpha 7 and alpha 9 alpha 10 Nicotinic Acetylcholine Receptors

Mechanism of Action and Structure-Activity Relationship of a-Conotoxin Mr1.1 at the Human a9a10 Nicotinic Acetylcholine Receptor

α*-Conotoxins Targeting Nicotinic Acetylcholine Receptors

Α-Conotoxin [s9a]txid Potently Discriminates Between Α3β4 and Α6/α3β4 Nicotinic Acetylcholine Receptors

Novel α-CTx TxIB Selectively Blocks α 6 / α 3 β 2 β 3 nAChRs 1 Characterization of a Novel α-Conotoxin from Conus textile that Selectively Targets α 6 / α 3 β 2 β 3 Nicotinic Acetylcholine Receptors

Progress in Study on Drug Design of Conotoxins

In vivo and in vitro testing of native α-conotoxins from the injected venom of Conus purpurascens

Characterization Of A Novel Alpha-Conotoxin From Conus Textile That Selectively Targets Alpha 6/Alpha 3 Beta 2 Beta 3 Nicotinic Acetylcholine Receptors

Alanine-Scanning Mutagenesis of Α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor